Familial-genetic counselling for breast/ovarian cancers is a process initia
ted by a proband, and designed for all her/his blood relatives. This study
focused on family members' uptake of an invitation to participate in counse
lling as a function of proband and family determinants. Of 163 breast/ovari
an syndrome families tested, 67 carrying one of the three known Jewish muta
tions were included. For both the proband and family members, demographic v
ariables, cancer status, position in the family and type of referral (proba
nd only) were examined. Eligible family members' uptake rate was 34%. Lower
family uptake was associated with the proband having cancer, and/or being
doctor-referred (vs self-referred. Individuals of either the proband's or o
lder generations had lower uptake rates compared with family members of you
nger generations. Being a cancer patient or a first degree relative of eith
er a cancer patient or the proband was related to higher uptake. The study
results indicate that baseline information routinely gathered by counsellin
g services can be useful in predicting uptake. Providing insight into compl
ex barriers to genetic counselling, these results also suggest potential di
rections for interventions to improve uptake, thereby enhancing individuals
' abilities to make informed decisions regarding issues such as genetic tes
ting. Copyright (C) 2000 John Wiley & Sons, Ltd.